Consensus and disputes on the adjuvant therapy for non-small cell lung cancer with positive surgical margins
10.3760/cma.j.cn113030-20190409-00125
- VernacularTitle:切缘阳性非小细胞肺癌术后辅助治疗现状与争议
- Author:
Meng YUAN
1
;
Yu MEN
;
Jingjing KANG
;
Xin SUN
;
Maoyuan ZHAO
;
Xu YANG
;
Yongxing BAO
;
Zhouguang HUI
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科 100021
- From:
Chinese Journal of Radiation Oncology
2020;29(10):904-908
- CountryChina
- Language:Chinese
-
Abstract:
For non-small cell lung cancer (NSCLC) patients with positive surgical margins, the survival rates can be dramatically decreased. However, high-level evidence is lacking in the standard adjuvant treatment for NSCLC patients with positive surgical margins. In this article, consensus and disputes on the adjuvant therapy for NSCLC patients with positive surgical margins were reviewed.
